Recognizing the resilience of children and families fighting neuroblastoma and supporting clinicians and researchers.

The bill supports designating September 3, 2026, as "Neuroblastoma Awareness Day" to recognize the resilience of children and families battling this disease. It highlights the challenges of treating high-risk neuroblastoma, which includes chemotherapy, surgery, and other therapies. The bill also acknowledges the significant health complications survivors may face and the need for continued research and therapeutic development. It aims to increase awareness to improve outcomes and drive investment in research.

Recognizing the resilience of children and families fighting neuroblastoma and supporting clinicians and researchers.

The bill supports designating September 3, 2026, as "Neuroblastoma Awareness Day" to recognize the resilience of children and families battling this disease. It highlights the challenges of treating high-risk neuroblastoma, which includes chemotherapy, surgery, and other therapies. The bill also acknowledges the significant health complications survivors may face and the need for continued research and therapeutic development. It aims to increase awareness to improve outcomes and drive investment in research.